Literature DB >> 12453875

Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis.

Sandra H P Oliveira1, Dennis D Taub, James Nagel, Robert Smith, Cory M Hogaboam, Aaron Berlin, Nicholas W Lukacs.   

Abstract

Eosinophils are effector cells that play an important role in the damage induced by the allergic process by releasing inflammatory mediators and proteolytic factors after activation. Stem cell factor (SCF) is a primary cytokine involved in hematopoiesis and mast cell differentiation, proliferation, and activation. Studies have also indicated that SCF is directly involved in pathogenesis of allergic airway inflammation. In the present study, we examined the ability of SCF to activate murine eosinophils for increased mediator release and up-regulation of chemokines. Initial data demonstrated that eosinophils have significant levels of surface c-kit protein, SCF receptor. SCF-activated eosinophils degranulate and release eosinophil peroxidase and leukotriene C(4) in a dose-dependent manner. In addition, SCF was further shown to induce the release of CC chemokines, RANTES, macrophage-derived chemokine (MDC), macrophage inflammatory protein-1beta (MIP-1beta), and C10 from eosinophils. To identify the extent of SCF-induced activation of eosinophils, we also performed gene array analysis using an array containing 1153 genes related to inflammation, including cytokines and their receptors, growth factors, structural and cytoskeletal genes, signal transduction genes as well as several other classes related to immune/inflammatory responses. The gene analysis indicated that more than 150 genes were significantly up-regulated in eosinophils after SCF stimulation. The gene array results were verified using a quantitative real-time polymerase chain reaction analysis to identify the expression of several chemokine and chemokine receptor genes. Altogether, these studies indicate that SCF is a potent eosinophil degranulator and activator that may play a number of roles during an inflammatory/immune response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453875     DOI: 10.1182/blood.V100.13.4291

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Asthma: new developments in cytokine regulation.

Authors:  R J Boyton; D M Altmann
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

Review 2.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

Review 3.  Contributions of electron microscopy to understand secretion of immune mediators by human eosinophils.

Authors:  Rossana C N Melo; Ann M Dvorak; Peter F Weller
Journal:  Microsc Microanal       Date:  2010-09-27       Impact factor: 4.127

Review 4.  Signaling of c-kit in dendritic cells influences adaptive immunity.

Authors:  Prabir Ray; Nandini Krishnamoorthy; Timothy B Oriss; Anuradha Ray
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

5.  Intranasal sirna targeting c-kit reduces airway inflammation in experimental allergic asthma.

Authors:  Wei Wu; Hui Chen; Ya-Ming Li; Sheng-Yu Wang; Xin Diao; Kai-Ge Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

6.  Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling.

Authors:  Vladislav A Dolgachev; Matthew R Ullenbruch; Nicholas W Lukacs; Sem H Phan
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

7.  Eosinophil activation of fibroblasts from chronic allergen-induced disease utilizes stem cell factor for phenotypic changes.

Authors:  Vladislav Dolgachev; Aaron A Berlin; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

8.  Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease.

Authors:  Andrew Rasky; David M Habiel; Susan Morris; Matthew Schaller; Bethany B Moore; Sem Phan; Steven L Kunkel; Martin Phillips; Cory Hogaboam; Nicholas W Lukacs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-20       Impact factor: 5.464

Review 9.  Functional deregulation of KIT: link to mast cell proliferative diseases and other neoplasms.

Authors:  Glenn Cruse; Dean D Metcalfe; Ana Olivera
Journal:  Immunol Allergy Clin North Am       Date:  2014-03-12       Impact factor: 3.479

10.  Stem cell factor and its soluble receptor (c-kit) in serum of asthmatic patients- correlation with disease severity.

Authors:  Joanna S Makowska; Malgorzata Cieslak; Marek L Kowalski
Journal:  BMC Pulm Med       Date:  2009-06-01       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.